Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Gibble TH, Abreu MT, Lee SD, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Panaccione R, Dignass A. Sands BE, et al. Among authors: clemow db. Inflamm Bowel Dis. 2024 Oct 25:izae253. doi: 10.1093/ibd/izae253. Online ahead of print. Inflamm Bowel Dis. 2024. PMID: 39448057
Medical Writing Competency Model - Section 1: Functions, Tasks, and Activities.
Clemow DB, Wagner B, Marshallsay C, Benau D, L'Heureux D, Brown DH, Dasgupta DG, Girten E, Hubbard F, Gawrylewski HM, Ebina H, Stoltenborg J, York JP, Green K, Wood LF, Toth L, Mihm M, Katz NR, Vasconcelos NM, Sakiyama N, Whitsell R, Gopalakrishnan S, Bairnsfather S, Wanderer T, Schindler TM, Mikyas Y, Aoyama Y. Clemow DB, et al. Ther Innov Regul Sci. 2018 Jan;52(1):70-77. doi: 10.1177/2168479017721585. Epub 2017 Sep 1. Ther Innov Regul Sci. 2018. PMID: 29714611
Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.
Dubinsky MC, Clemow DB, Hunter Gibble T, Li X, Vermeire S, Hisamatsu T, Travis SPL. Dubinsky MC, et al. Among authors: clemow db. Crohns Colitis 360. 2022 Dec 13;5(1):otac044. doi: 10.1093/crocol/otac044. eCollection 2023 Jan. Crohns Colitis 360. 2022. PMID: 36777368 Free PMC article.
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study.
Sands BE, D'Haens G, Clemow DB, Irving PM, Johns JT, Hunter Gibble T, Abreu MT, Lee S, Hisamatsu T, Kobayashi T, Dubinsky MC, Vermeire S, Siegel CA, Peyrin-Biroulet L, Moses RE, Milata J, Arora V, Panaccione R, Dignass A. Sands BE, et al. Among authors: clemow db. Inflamm Bowel Dis. 2024 Dec 5;30(12):2245-2258. doi: 10.1093/ibd/izae024. Inflamm Bowel Dis. 2024. PMID: 38459910 Free PMC article. Clinical Trial.
Patient and Healthcare Professional Satisfaction, Acceptability, and Preference Experiences With Mirikizumab Administration for Ulcerative Colitis: An International Survey.
Clemow D, Radawski C, Milata J, Alaka K, Gibble TH, Schaum A, Ezennia O, Martinez N, Szaloki T, Ito Y, Rodriguez D, Kirk K. Clemow D, et al. Crohns Colitis 360. 2024 Oct 4;6(4):otae054. doi: 10.1093/crocol/otae054. eCollection 2024 Oct. Crohns Colitis 360. 2024. PMID: 39473630 Free PMC article.
37 results